The drugmaker revised its revenue guidance for 2025, saying it now expects $62 billion in revenue for the year.
www.marketwatch.com
#Pfizers #stock #drops #lowers #revenue #forecast
Pfizer’s stock drops after it lowers its revenue forecast
Related Posts
Waymo crosses 450,000 weekly paid rides, widening Tesla lead
Waymo driverless taxi parks in lower Manhattan in New York City, U.S., Nov. 26, 2025. Brendan McDermid | Reuters Waymo,…
Banzai International Moves Ahead with One-for-Ten Stock Split
Banzai International, Inc. (NASDAQ:BNZI) is among the fundamentally strong penny stocks to invest in. On Thursday, Banzai International, Inc. (NASDAQ:BNZI)…
PBS, NPR funding at risk as House votes on $9.4 billion in DOGE cuts
U.S. President Donald Trump and U.S. House Speaker Mike Johnson react during an Invest America Roundtable in the State Dining…